News | Radiation Oncology | May 08, 2020

The NCI Cancer Imaging Program is utilizing The Cancer Imaging Archive resource to de-identify and publicly host an initial COVID-19 chest (CT and plain film) reference image dataset for health care providers worldwide and researchers interested in pursuing artificial intelligence (AI) approaches for diagnosis and recovery follow-up

During the COVID-19 pandemic, the National Cancer Institute (NCI) is fully operating and continues to lead, conduct and support cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives, according to an editorial by Janet Eary, M.D., and Lalitha Shankar, M.D., Ph.D., published today in the journal Radiology: Imaging Cancer.

May 8, 2020 — During the COVID-19 pandemic, the National Cancer Institute (NCI) is fully operating and continues to lead, conduct and support cancer research across the nation to advance scientific knowledge and help all people live longer, healthier lives, according to an editorial by Janet Eary, M.D., and Lalitha Shankar, M.D., Ph.D., published today in the journal Radiology: Imaging Cancer.

The editorial outlines the NCI’s research efforts to find effective vaccine and therapy options for COVID-19 and explains how the NCI Cancer Imaging Program is using The Cancer Imaging Archive resource to de-identify and publicly host an initial COVID-19 chest CT and X-ray reference image dataset for health care providers.

The authors also discuss steps taken to address access to care and other challenges facing cancer patients during the pandemic. Because cancer patients are at a uniquely high risk for poor outcome from coronavirus infection, NCI recently announced the development of a clinical trial to study the natural history of COVID-19 in affected cancer patients. The data gleaned from the trial will be useful for research aimed at understanding the pathobiology of the coronavirus in this vulnerable patient population.

The authors stress that communication and interpersonal interaction are vital during this public health crisis and emphasize the importance of adapting to new ways to share knowledge and information.

“For the future, we can continue to realize the value of these interactions and plan the use of our finite resources accordingly knowing that we can accomplish much with technology. In doing so, we will be able to heighten our focus on harnessing AI approaches and other data-based interventions to continue to make advances in promoting health across all our constituencies,” they wrote.

For more information: COVID-19 Update from the NCI Cancer Imaging Program


Related Content

News | Radiology Business

May 20, 2024 — Associated Medical Professionals of NY (A.M.P.) announced that internationally recognized radiation ...

Time May 20, 2024
arrow
News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
News | Radiation Therapy

May 16, 2024 — Today marks a significant milestone in cancer care with the introduction of bipartisan federal ...

Time May 16, 2024
arrow
News | FDA

May 14, 2024 — Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA ...

Time May 14, 2024
arrow
News | Radiology Business

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on ...

Time May 14, 2024
arrow
News | Artificial Intelligence

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high ...

Time May 14, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

One on One interviews with radiology trailblazers and historic FDA clearances made the top-read list for April. Take a ...

Time May 03, 2024
arrow
Feature | Radiation Dose Management | By Christine Book

Advances in the growing radiation dose management market are continually helping those who administer treatment to focus ...

Time May 03, 2024
arrow
News | Artificial Intelligence

May 2, 2024 — Radformation, Inc., a leader in automation solutions for cancer care, announced today that it has acquired ...

Time May 02, 2024
arrow
Subscribe Now